Video: Protas supports US community research with Milken Institute
ENRICH-CT is enabling more inclusive clinical research in the US, supported by Protas.
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
ENRICH-CT is enabling more inclusive clinical research in the US, supported by Protas.
Protas joins colleagues at Milken Institute Global Conference to discuss democratic clinical trials.
Protas will advise GSK on clinical trial protocols across a range of late-phase investigational products.
Prof Sir Martin Landray joins Salesforce and Slalom to talk about our collaboration in revolutionising clinical trials.
Prof Sir Martin Landray writes about how clinical trials are key to common disease prevention, early detection and treatment.
As part of New Scientist’s 2023 campaign on innovation in clinical research and development, Prof Sir Martin Landray explores the pressing need to transform clinical…
The international accreditation acknowledges our approach to quality.
Abbie Gerard shares what motivated her to move from academia to a new not-for-profit.
Protas will provide expertise to the portfolio biopharma on a range of drug development programmes.
The Executive Vice President of Milken Institute Health shares what drew her to Protas.
Venkat Rajendran shares his exciting, and sometimes unusual, career trajectory.
Jonathan Solomon shares what drew him from private practice to a clinical trial not-for-profit.